Whelton Seamus P, Hyre Amanda D, Pedersen Bonnie, Yi Yeonjoo, Whelton Paul K, He Jiang
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana 70112, USA.
J Hypertens. 2005 Mar;23(3):475-81. doi: 10.1097/01.hjh.0000160199.51158.cf.
We conducted a meta-analysis of 25 randomized controlled trials published in English-language journals before February 2004, to assess the effect of dietary fiber intake on blood pressure (BP).
Using a standardized protocol, information on study design, sample size, participant characteristics, duration of follow-up and change in mean BP, was abstracted. The data from each study were pooled using a random effects model to provide an overall estimate of dietary fiber intake on BP.
Dietary fiber intake was the only significant intervention difference between the active and control groups.
Overall, dietary fiber intake was associated with a significant -1.65 mmHg [95% confidence interval (CI), -2.70 to -0.61] reduction in diastolic BP (DBP) and a non-significant -1.15 mmHg (95% CI, -2.68 to 0.39) reduction in systolic BP (SBP). A significant reduction in both SBP and DBP was observed in trials conducted among patients with hypertension (SBP -5.95 mmHg, 95% CI, -9.50 to -2.40; DBP -4.20 mmHg, 95% CI, -6.55 to -1.85) and in trials with a duration of intervention > or = 8 weeks (SBP -3.12 mmHg, 95% CI, -5.68 to -0.56; DBP -2.57 mmHg, 95% CI, -4.01 to -1.14).
Our results indicate that increased intake of dietary fiber may reduce BP in patients with hypertension and suggests a smaller, non-conclusive, reduction in normotensives. An intervention period of at least 8 weeks may be necessary to achieve the maximum reduction in BP. Our findings warrant conduct of additional clinical trials with a larger sample size and longer period of intervention to examine the effect of dietary fiber intake on BP.
我们对2004年2月之前发表在英文期刊上的25项随机对照试验进行了荟萃分析,以评估膳食纤维摄入量对血压(BP)的影响。
采用标准化方案,提取有关研究设计、样本量、参与者特征、随访时间以及平均血压变化的信息。使用随机效应模型汇总每项研究的数据,以提供膳食纤维摄入量对血压影响的总体估计。
膳食纤维摄入量是活性组与对照组之间唯一显著的干预差异。
总体而言,膳食纤维摄入量与舒张压(DBP)显著降低1.65 mmHg[95%置信区间(CI),-2.70至-0.61]相关,而与收缩压(SBP)非显著降低1.15 mmHg(95%CI,-2.68至0.39)相关。在高血压患者中进行的试验(SBP降低5.95 mmHg,95%CI,-9.50至-2.40;DBP降低4.20 mmHg,95%CI,-6.55至-1.85)以及干预持续时间≥8周的试验(SBP降低3.12 mmHg,95%CI,-5.68至-0.56;DBP降低2.57 mmHg,95%CI,-4.01至-1.14)中,均观察到SBP和DBP显著降低。
我们的结果表明,增加膳食纤维摄入量可能会降低高血压患者的血压,并表明在血压正常者中会有较小的、不确定的降低。可能需要至少8周的干预期才能实现血压的最大降低。我们的研究结果值得开展更多样本量更大、干预时间更长的临床试验,以研究膳食纤维摄入量对血压的影响。